Collegium Pharmaceutical, Inc. (COLL) Company Total Revenue

Collegium Pharmaceutical (COLL) maintains a resilient business model due to its focus on the US market, which eliminates the impact of sanctions. The company's sales volume confirms this stability, with the value of 0.82 serving as a baseline indicator. Despite global risks of raw material supply chain disruptions, Collegium Pharmaceutical is expanding its influence through partnerships with pharmacy chains and responsible medication use programs.

COLL - Collegium Corp Company Revenue over the range 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for Collegium Pharma (COLL)

- stock value and consensus price forecast:

Stock Quotes collegiumpharma.com|COLL - Price Target Chart

- market capitalization details:

Market Value Collegium Pharmaceutical Inc|COLL - Total Company Value

- book value of equity indicators:

Net Assets per Single Share Collegium Pharmaceutical|COLL - Company Book Value|Market Value to Book Value Ratio collegiumpharma.com|COLL - Company Total Assets

- company liabilities and liquidity data:

Debt to Capital Collegium Pharmaceutical|COLL - Long-Term Debt to Capital|Short-Term Indebtedness to Equity Collegium Pharmaceutical Inc|COLL - Company Aggregate Debts|Debts to Net Assets Collegium Corp|COLL - Company Long-Term Liabilities|Company Short-Term Debts Collegium Pharmaceutical|Quick Liquidity Indicator collegiumpharma.com

- earnings and market ratios statistics:

COLL - Net Income|Expected Net Income Collegium Pharmaceutical|COLL - Price to Earnings Ratio|Price to Expected Earnings Ratio Collegium Pharmaceutical, Inc.|COLL - PEG Multiple|Business Value to Operating Income Before Depreciation Collegium Pharma|COLL - Operating profit EBITDA|Net earnings per share (EPS TTM) Collegium Pharmaceutical|COLL - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months collegiumpharma.com|COLL - Earnings per share growth in current year|Expected earnings per share growth for next year Collegium Pharmaceutical

- sales volume and revenue indicators:

COLL - Revenue and Sales Volume|Projected Sales Volume Collegium Pharmaceutical|COLL - P/S Multiple|Forward Price-to-Revenue Multiple Collegium Pharma

Summary company analysis:Collegium Pharmaceutical

Original product of Collegium Pharmaceutical, Inc.

An investment audit of the issuer requires a detailed review of operational efficiency before purchasing the asset. This metric aggregates daily product sales revenue, measuring the actual pace of cash inflows. For Collegium Pharmaceutical (COLL), this reflects stable demand for mature analgesic drugs. Analyzing the company's total sales volume allows for the identification of deviations from shipment plans. Regular monitoring of the chart prevents the risk of profit shortfalls.

Competing companies